Photo taken from Aspira Women's Health/X
Aug 17, 2024, 12:31
Aspira Women’s Health reported it’s Q2 2024 Financial Results
Aspira Women’s Health shared on X:
“Aspira Women’s Health recently reported our Q2 2024 Financial Results with highlights including $2.4 million in OvaSuite℠ revenue, 6,471 units in volume, and a 16% decrease in cash utilization compared to Q1 2024.
For more details, check out our full PR.”
Source: Aspira Women’s Health/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46